Baloxavir Marboxil Reduces Median Length Of Flu Symptoms, Study Indicates.

MedPage Today (9/5, Walker) reports a phase III trial found the “antiviral agent baloxavir marboxil was safe and associated with a shorter median time to alleviation of influenza symptoms versus placebo in phase II and phase III trials.” However, “compar...